Scarica l'app Stockscreener
1.465
2.45%
0.035
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ERAS Giù?
Forum
Previsione
Precedente Chiudi:
$1.43
Aprire:
$1.43
Volume 24 ore:
381.60K
Relative Volume:
0.31
Capitalizzazione di mercato:
$415.02M
Reddito:
-
Utile/perdita netta:
$-125.04M
Rapporto P/E:
-1.7866
EPS:
-0.82
Flusso di cassa netto:
$-122.99M
1 W Prestazione:
+3.53%
1M Prestazione:
+3.17%
6M Prestazione:
-7.86%
1 anno Prestazione:
-39.21%
Intervallo 1D:
$1.4113
$1.4745
Intervallo di 1 settimana:
$1.34
$1.54
Portata 52W:
$1.01
$3.305
Erasca Inc Stock (ERAS) Company Profile
Nome
Erasca Inc
Settore
Industria
Telefono
(858) 465-6511
Indirizzo
10835 ROAD TO THE CURE, SUITE 140, SAN DIEGO
Confronta ERAS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ERAS
Erasca Inc
|
1.465 | 424.93M | 0 | -125.04M | -122.99M | -0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
377.83 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.00 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.63 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
667.94 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
296.00 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Erasca Inc Stock (ERAS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-26 | Iniziato | Raymond James | Outperform |
| 2024-11-18 | Iniziato | Jefferies | Buy |
| 2024-03-11 | Iniziato | CapitalOne | Overweight |
| 2024-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-10-11 | Iniziato | H.C. Wainwright | Buy |
| 2023-03-30 | Iniziato | Mizuho | Buy |
| 2023-02-24 | Iniziato | Goldman | Buy |
| 2023-02-03 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
Mostra tutto
Erasca Inc Borsa (ERAS) Ultime notizie
When is the best time to exit Erasca Inc.Free Real Market Momentum Signal Generator - Newser
Brokerages Set Erasca, Inc. (NASDAQ:ERAS) PT at $4.57 - Defense World
What technical models suggest about Erasca Inc.’s comebackTrading Volume Anomaly Summary and Insight - Newser
Erasca Inc. stock momentum explainedIn-Depth Stock Trading Volume Analysis - Newser
Is it too late to sell Erasca Inc.Chart Driven Entry Timing for Swing Trades - Newser
How to build a dashboard for Erasca Inc. stockFree Weekly Top Gainers Forecast Watchlist - Newser
Can Erasca Inc. Rally Enough to Break EvenWeekly Chart Analysis With Entry Advice Provided - metal.it
Heatmap Data Shows High Activity in Erasca Inc. SectorLow Risk Swing Trade Opportunities Identified - metal.it
Multi factor analysis applied to Erasca Inc.Summary of Reliable Long-Term Trade Models - Newser
Erasca discloses new GTPase KRAS mutant inhibitors - BioWorld MedTech
Fibonacci Levels Suggest Recovery for Erasca Inc.Consistent Gain Investment Strategies Emerge - beatles.ru
Why is Erasca Inc. stock attracting strong analyst attentionFree Predictions - Jammu Links News
What analysts say about Erasca Inc. stockFastest-growing stock picks - Jammu Links News
Erasca Receives FDA Clearance for First-in-Class Pan-KRAS Inhibitor, ERAS-4001, for Solid Tumors - MSN
Is it the right time to buy Erasca Inc. stockTap into rapid wealth building techniques - Jammu Links News
Is Erasca Inc. stock overvalued or undervaluedCapitalize on proven investment strategies - Jammu Links News
What catalysts could drive Erasca Inc. stock higher in 2025Massive portfolio appreciation - Jammu Links News
Published on: 2025-08-04 01:33:01 - Jammu Links News
When is Erasca Inc. stock expected to show significant growthGet professional guidance for market timing - Jammu Links News
How does Erasca Inc. compare to its industry peersDiscover market opportunities with expert help - Jammu Links News
What makes Erasca Inc. stock price move sharplyAchieve rapid portfolio growth with expert guidance - Jammu Links News
What is Erasca Inc. company’s growth strategyFree Daily Trading Room Entry - Jammu Links News
Is Erasca Inc. a growth stock or a value stockMaximize gains with data-driven stock picks - Jammu Links News
Predicting Erasca Inc. trend using moving averagesFree Daily Profit Focused Stock Screener - Newser
What institutional investors are buying Erasca Inc. stockGrow your portfolio with growth-oriented stocks - Jammu Links News
How does Erasca Inc. generate profit in a changing economyUnlock powerful stock screening tools - Jammu Links News
What are analysts’ price targets for Erasca Inc. in the next 12 monthsInvest smarter with data-backed insights - Jammu Links News
How to track smart money flows in Erasca Inc.Weekly Hot Stocks Based on Volume Flow - Newser
What are Erasca Inc. company’s key revenue driversPost Market Target Finder For Every Investor - Jammu Links News
Trend Reversal Possible in Erasca Inc. Charts IndicateStable Entry High Return Opportunities in Focus - metal.it
How many analysts rate Erasca Inc. as a “Buy”Financial News Planner For Beginners - Jammu Links News
Why Erasca Inc. stock attracts strong analyst attentionEntry and Exit Strategy Optimizer Tool Tested - metal.it
Is Erasca Inc. stock ready for a breakoutAI-Based Stock Behavior Forecast Engine - Newser
Can Erasca Inc. Overcome Bearish SentimentSecure Capital Picks With Upside Potential Tracked - beatles.ru
Machine Learning Models Forecast Erasca Inc. UptickPattern Breakout Entry Stock Forecast in Focus - beatles.ru
Can momentum traders help lift Erasca Inc.Long Term Stock Growth Plan Suggestions - Newser
Erasca Inc Azioni (ERAS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):